Learning Objectives:

  1. To describe rationale, early results of TMVR in MAC and tools to improve outcomes.
  2. To review how learnings of ViMAC experience have been applied to TMVR in other pathologies (MViV, MViR, non-calcified native MV).
  3. To delineate ongoing pivotal clinical trials of TMVR in MAC.
Session date: 
06/02/2023 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Mayra Guerrero, MD